Cargando…
Targeting Redox Metabolism in Pancreatic Cancer
Cell metabolism is reprogrammed in cancer cells to meet their high bioenergetics and biosynthetic demands. This metabolic reprogramming is accompanied by alterations in redox metabolism, characterized by accumulation of reactive oxygen species (ROS). Elevated production of ROS, mostly by mitochondri...
Autores principales: | Abdel Hadi, Nadine, Reyes-Castellanos, Gabriela, Carrier, Alice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913542/ https://www.ncbi.nlm.nih.gov/pubmed/33546421 http://dx.doi.org/10.3390/ijms22041534 |
Ejemplares similares
-
Autophagy Contributes to Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Tumors
por: Reyes-Castellanos, Gabriela, et al.
Publicado: (2022) -
Mitochondrial Metabolism in PDAC: From Better Knowledge to New Targeting Strategies
por: Reyes-Castellanos, Gabriela, et al.
Publicado: (2020) -
Targeting Mitochondrial Complex I Overcomes Chemoresistance in High OXPHOS Pancreatic Cancer
por: Masoud, Rawand, et al.
Publicado: (2020) -
Combining the antianginal drug perhexiline with chemotherapy induces complete pancreatic cancer regression in vivo
por: Reyes-Castellanos, Gabriela, et al.
Publicado: (2023) -
Redox Homeostasis and Metabolism in Cancer: A Complex Mechanism and Potential Targeted Therapeutics
por: Ghoneum, Alia, et al.
Publicado: (2020)